Inhibition of monoamine oxidase A by beta-carboline derivatives.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Archives of Biochemistry and Biophysics

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 8990278
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Harman (1-methyl-beta-carboline) is a natural inhibitor of monoamine oxidase type A in rats.

  1994cited by this paper
• Potential bioactivated neurotoxicants, N-methylated beta-carbolinium ions, are present in human brain.

  1993cited by this paper
• 5-[4-(benzyloxy)phenyl]-1,3,4-oxadiazol-2(3H)-one derivatives and related analogues: new reversible, highly potent, and selective monamine oxidase type B inhibitors.

  1993cited by this paper
• Indole-N-methylated beta-carbolinium ions as potential brain-bioactivated neurotoxins.

  1992cited by this paper
• Interaction of 1‐Methyl‐4‐Phenylpyridinium Ion (MPP+) and Its Analogs with the Rotenone/Piericidin Binding Site of NADH Dehydrogenase

  1991cited by this paper
• Differences in substrate specificities of monoamine oxidase A from human liver and placenta.

  1991cited by this paper
• [3H]Harman Binding Experiments. I: A Reversible and Selective Radioligand for Monoamine Oxidase Subtype A in the CNS of the Rat

  1991cited by this paper
• Dopamine uptake inhibitory capacities of beta-carboline and 3,4-dihydro-beta-carboline analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation products.

  1990cited by this paper
• Quantitative autoradiography of [3H]norharman [( 3H]beta-carboline) binding sites in the rat brain.

  1990cited by this paper
• Mitochondrial respiratory inhibition by N-methylated beta-carboline derivatives structurally resembling N-methyl-4-phenylpyridine.

  1990cited by this paper
• A new class of powerful inhibitors of monamine oxidase A.

  1990cited by this paper
• Oxidation of Analogs of l‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine by Monoamine Oxidases A and B and the Inhibition of Monoamine Oxidases by the Oxidation Products

  1989cited by this paper
• Structural dependence of the inhibition of mitochondrial respiration and of NADH oxidase by 1-methyl-4-phenylpyridinium (MPP+) analogs and their energized accumulation by mitochondria.

  1989cited by this paper
• cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties.

  1988cited by this paper
• Human liver MAO-A and MAO-B separated by immunoaffinity chromatography with MAO-B-specific monoclonal antibody.

  1982cited by this paper
• Iron content and spectral properties of highly purified bovine liver monoamine oxidase.

  1981cited by this paper
• Identification and quantification of 1,2,3,4-tetrahydro-beta-carboline, 2-methyl-1,2,3,4-tetrahydro-beta-carboline, and 6-methoxy-1,2,3,4-tetrahydro-beta-carboline as in vivo constituents of rat brain and adrenal gland.

  1981cited by this paper
• Differences in A and B forms of monoamine oxidase revealed by limited proteolysis and peptide mapping

  1979cited by this paper
• [3H]HARMALINE AS A SPECIFIC LIGAND OF MAO A—I. PROPERTIES OF THE ACTIVE SITE OF MAO A FROM RAT AND BOVINE BRAINS

  1979cited by this paper
• Monoamine oxidase from beef liver mitochondria: simplified isolation procedure, properties, and determination of its cysteinyl flavin content.

  1979cited by this paper
• Inhibitors of monoamine oxidase. Influence of methyl substitution on the inhibitory activity of beta-carbolines.

  1968cited by this paper

• The dual fate of DYRK2 in cancer: balancing the light and dark side of tumorigenesis

  2026cites this paper
• Monoamine Oxidase Inhibitors Present in Tobacco Modulate Dopamine Balance Via the Dopamine Transporter

  2025cites this paper
• Development of a Physiologically Based Pharmacokinetic Model of N,N-Dimethyltryptamine, Harmine, and Their Interactions from Ayahuasca in Rats and Humans.

  2025cites this paper
• In Vitro and In Silico Studies on the Anti-H1N1 Activity of Bioactive Compounds from Marine-Derived Streptomyces ardesiacus

  2025cites this paper
• Ultrasensitive spectrofluorimetric analysis of harmalacidine HCl: A potent underexplored MAO-A inhibitor from Peganum harmala L.

  2025cites this paper
• Fluorescent Spectrofluorimetric Method for the Quantification of Harmine in Human Plasma Using Tinopal CBS‐X

  2025cites this paper
• Clinical pharmacology of ayahuasca: potential applications and future considerations

  2025cites this paper
• Beta-Carboline Alkaloids: An Integrative Review of Chemistry, Structure–Activity Relationships and Pharmacological Significance

  2025cites this paper
• Harmine suppresses pancreatic cancer through DYRK1A-mediated hyper-activated RAS/MAPK inhibition.

  2025cites this paper
• Development of 5-phenylnitro bearing furan-based chalcones as a new class of potent MAO-B inhibitors.

  2025cites this paper
• Harnessing Pharmacogenomics in Clinical Research on Psychedelic‐Assisted Therapy

  2024influential citation
• Human CYP2D6 varies across the estrous cycle in brains of transgenic mice altering drug response.

  2024cites this paper
• Resource distribution, pharmacological activity, toxicology and clinical drugs of β-Carboline alkaloids: An updated and systematic review.

  2024cites this paper
• Nabiximols (NBX) suppresses tremor in a rat Harmaline model of essential tremor.

  2024cites this paper
• Dissecting the role of SMN multimerization in its dissociation from the Cajal body using harmine as a tool compound.

  2024cites this paper
• Evaluation of the Neuroprotective Effect of Total Glycosides of Cistanche deserticola and Investigation of Novel Brain-Targeting Natural MAO-B Inhibitors.

  2024cites this paper
• Effect of Peganum harmala Total Alkaloid Extract on Sexual Behavior and Sperm Parameters in Male Mice

  2023cites this paper
• The neuroanatomical basis of the 5-HT syndrome and harmaline-induced tremor.

  2023cites this paper
• β-Carboline Alkaloids in Soy Sauce and Inhibition of Monoamine Oxidase (MAO)

  2023cites this paper
• Review of β‐carboline and its derivatives as selective MAO‐A inhibitors

  2023cites this paper
• Discerning of isatin-based monoamine oxidase (MAO) inhibitors for neurodegenerative disorders by exploiting 2D, 3D-QSAR modelling and molecular dynamics simulation

  2023cites this paper
• Impact of genetic variants within serotonin turnover enzymes on human cerebral monoamine oxidase A in vivo

  2023cites this paper
• From Monoamine Oxidase Inhibition to Antiproliferative Activity: New Biological Perspectives for Polyamine Analogs

  2023cites this paper
• A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond.

  2023cites this paper
• Antifungal Activity of β-Carboline Alkaloids Compound and Its Resistance Mechanism on Peronophythora Litchii

  2022cites this paper
• The chromosome 21 kinase DYRK1A: emerging roles in cancer biology and potential as a therapeutic target

  2022cites this paper
• Cerebello-Thalamo-Cortical Network Dynamics in the Harmaline Rodent Model of Essential Tremor

  2022cites this paper
• Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant

  2022cites this paper
• Altered states, alkaloids, and catatonia: Monoaminoxidase inhibitors and their role in the history of psychopharmacology

  2022cites this paper
• Harmol alleviates dimethylhydrazine induced colon cancer by downregulating Bcl2/IL-6/TNF-α expression in association with p53 mediated apoptosis

  2022cites this paper
• Computational Insights into β-Carboline Inhibition of Monoamine Oxidase A

  2022influential citation
• A natural compound harmine decreases melanin synthesis through regulation of the DYRK1A/NFATC3 pathway.

  2021cites this paper
• Dyrk1a from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome

  2021cites this paper
• The Pathophysiology and Treatment of Essential Tremor: The Role of Adenosine and Dopamine Receptors in Animal Models

  2021cites this paper
• Identification of harmine and β-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies.

  2021cites this paper
• Discovery of Hydroxybenzothiazole Urea Compounds as Multitargeted Agents Suppressing Major Cytotoxic Mechanisms in Neurodegenerative Diseases.

  2021cites this paper
• GSK-3β, FYN, and DYRK1A: Master Regulators in Neurodegenerative Pathways

  2021cites this paper
• Sex and the serotonergic underpinnings of depression and migraine.

  2020cites this paper
• Opipramol Inhibits Lipolysis in Human Adipocytes without Altering Glucose Uptake and Differently from Antipsychotic and Antidepressant Drugs with Adverse Effects on Body Weight Control

  2020cites this paper
• Harmaline potentiates morphine-induced antinociception via affecting the ventral hippocampal GABA-A receptors in mice.

  2020cites this paper
• β-Carbolines found in cigarette smoke elevate intracranial self-stimulation thresholds in rats.

  2020cites this paper
• Plasticity as a therapeutic target for improving cognition and behavior in Down syndrome.

  2020cites this paper
• Harmine and Piperlongumine Revert TRIB2-Mediated Drug Resistance

  2020cites this paper
• Acute and Sub-acute Toxic Effects of Algerian Peganum harmala L. Crud Extract

  2020cites this paper
• Anti-inflammatory activity of ayahuasca and its implications for the treatment of neurological and psychiatric diseases.

  2020cites this paper
• Reactivity and degradation products of tryptophan in solution and proteins.

  2020cites this paper
• How to Separate Kinase Inhibition from Undesired Monoamine Oxidase A Inhibition—The Development of the DYRK1A Inhibitor AnnH75 from the Alkaloid Harmine

  2020cites this paper
• An isothermal shift assay for proteome scale drug-target identification

  2020cites this paper
• Zinc Complexes with Nitrogen Donor Ligands as Anticancer Agents

  2020cites this paper
• Pre-clinical investigations of β-carboline alkaloids as antidepressant agents: A systematic review.

  2019cites this paper
• Toxicological Aspects and Determination of the Main Components of Ayahuasca: A Critical Review

  2019cites this paper
• Natural β-carboline alkaloids regulate the PI3K/Akt/mTOR pathway and induce autophagy in insect Sf9 cells.

  2019cites this paper
• In vivo and in vitro metabolism and pharmacokinetics of cholinesterase inhibitor deoxyvasicine from aerial parts of Peganum harmala Linn in rats via UPLC-ESI-QTOF-MS and UPLC-ESI-MS/MS.

  2019cites this paper
• [b]-Annulated Halogen-Substituted Indoles as Potential DYRK1A Inhibitors

  2019cites this paper
• Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.

  2019cites this paper
• Umbelliferone derivatives exert neuroprotective effects by inhibiting monoamine oxidase A, self-amyloidβ aggregation, and lipid peroxidation.

  2019cites this paper
• Inhibitory effects of agmatine on monoamine oxidase (MAO) activity: Reconciling the discrepancies

  2018cites this paper
• HPLC-UV assays for evaluation of inhibitors of mono and diamine oxidases using novel phenyltetrazolylalkanamine substrates.

  2018cites this paper
• Harmine promotes periodontal ligament cell-induced tissue regeneration.

  2018cites this paper
• Kinetics, mechanism, and inhibition of monoamine oxidase

  2018cites this paper
• Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.

  2018cites this paper
• [11C]Harmine Binding to Brain Monoamine Oxidase A: Test-Retest Properties and Noninvasive Quantification

  2018cites this paper
• Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?

  2017cites this paper
• Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits

  2017cites this paper
• Potent inhibition of human organic cation transporter 2 (hOCT2) by β-carboline alkaloids

  2017influential citation
• A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum.

  2017cites this paper
• Potent Selective Inhibition of Monoamine Oxidase A by Alternariol Monomethyl Ether Isolated from Alternaria brassicae.

  2017cites this paper
• Distribution, Status, Pharmacological, and Traditional importance of Peganum harmala L

  2017cites this paper
• Selective inhibition of monoamine oxidase A by purpurin, an anthraquinone.

  2017cites this paper
• Harmine, a Novel DNA Methyltransferase 1 Inhibitor in the Leukemia Cell Line

  2017cites this paper
• Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration

  2016cites this paper
• DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance

  2016cites this paper
• Transition-metal norharmane compounds as possible cytotoxic agents: New insights based on a coordination chemistry perspective.

  2016cites this paper
• DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome

  2016cites this paper
• Design, Synthesis and in vitro Evaluation of Indolotacrine Analogues as Multitarget‐Directed Ligands for the Treatment of Alzheimer's Disease

  2016cites this paper
• Pramipexole at a Low Dose Induces Beneficial Effect in the Harmaline‐induced Model of Essential Tremor in Rats

  2016cites this paper
• Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice

  2016cites this paper
• A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition

  2016cites this paper
• Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens.

  2016cites this paper
• DYRK1A inhibition as potential treatment for Alzheimer's disease.

  2016cites this paper
• Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.

  2016cites this paper
• DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications.

  2015cites this paper
• The Relationship of Alcohol Dependence to Monoamine Oxidase A

  2015cites this paper
• Effects of harmine, an acetylcholinesterase inhibitor, on spatial learning and memory of APP/PS1 transgenic mice and scopolamine-induced memory impairment mice.

  2015cites this paper
• Selective binding to monoamine oxidase A: in vitro and in vivo evaluation of (18)F-labeled β-carboline derivatives.

  2015cites this paper
• Inhibitive activities detection of monoamine oxidases (MAO) A and B inhibitors in human liver MAO incubations by UPLC-ESI-MS/MS.

  2015cites this paper
• The hallucinogenic world of tryptamines: an updated review

  2015cites this paper
• DYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis

  2015cites this paper
• Discovery and optimization of a novel series of Dyrk1B kinase inhibitors to explore a MEK resistance hypothesis.

  2015cites this paper
• 10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A

  2015cites this paper
• Parameter evaluation and fully-automated radiosynthesis of [11C]harmine for imaging of MAO-A for clinical trials

  2015cites this paper
• Inhibition of Monoamine Oxidase by Anithiactins from Streptomyces sp.

  2015cites this paper
• Biosensor based on inhibition of monoamine oxidases A and B for detection of β-carbolines.

  2015cites this paper
• Novel harmine analogues and the effect on dual specificity kinase activity of DYRK1A

  2015cites this paper
• Apomorphine enhances harmaline-induced tremor in rats

  2015cites this paper
• Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors.

  2015cites this paper
• Sequence Specific Binding of Beta Carboline Alkaloid Harmalol with Deoxyribonucleotides: Binding Heterogeneity, Conformational, Thermodynamic and Cytotoxic Aspects

  2014cites this paper
• Harmine induces apoptosis and inhibits tumor cell proliferation, migration and invasion through down-regulation of cyclooxygenase-2 expression in gastric cancer.

  2014cites this paper
• Design and Synthesis of a Library of Lead-Like 2,4-Bisheterocyclic Substituted Thiophenes as Selective Dyrk/Clk Inhibitors

  2014cites this paper
• DYRK1A: a potential drug target for multiple Down syndrome neuropathologies.

  2014cites this paper